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Abstract
It has been shown that lung epithelial cells
have displayed to be active effectors of
microbial defense. Stimulation of these
cells by a treatment consisting of the
combination of Toll-like Receptor (TLR)
agonists have shown to increase defenses
towards commonly lethal pneumonias. This
study examined the synergistic interactions
between TLR2/6 and TLR9, more
commonly known as Pam2-ODN, and the
resulting immune response of MLE15, a
mouse lung epithelial cell line. Results
were collected by measuring the increased
production of known antimicrobial peptide
(AMP) receptors, indicating an increased
immune response. The AMP of interest in
this study is Serum amyloid A-3 (SAA3).
SAA3 levels were measured after the
addition of treatment at various time
frames between 1-6 hours. Results
showed the most significant level of SAA3
production at 2 hours and 4 hours,
suggesting these time frames as optimal
following the addition of treatment.

regulation of pro-inflammatory immune
response. The CpG motif that is
responsible for this cascade in TLR9 is
oligonucleotide (ODN) M362. Combined,
the two ligands: known as Pam2-ODN,
displays an increased immune response to
pneumonia infection4.

the cells reached full confluence,
treatments were added according to the
time frame indicated (e.g. 2 hr. group was
treated for 2 hours). Once the time frame
was complete, cells were then lysed, and
RNA was extracted using a spin column.
Gene expression of SAA3 was measured
by qRT-PCR. The data were then analyzed
using the GraphPad software.

Further studies involving in-vitro infection
models need to be performed to assess
the protectiveness of SAA3 and other
antimicrobial peptides induced by Pam2ODN. Results will allow for increased
insights into the mechanism of action
behind this induced protection.
Fig. 1 Depiction of the cascade reactions involved in the
synergistic combination of TLR 2/6 and TLR9. The
agonists Pam2Csk4 and ODN are depicted as the
initiating steps in the cascade. AMP and Reactive
Oxygen Species (ROS) are depicted as final products.
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Methodology
This study consisted of various timed trials
ran in five phases: cell culture, addition of
treatment,
RNA
Extraction,
cDNA
conversion, and qRT-PCR analysis. Once
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Previous
microarray
analyses
have
indicated upregulated genes coding for
antimicrobial peptides (AMP’s) after the
addition of PAM2-ODN treatment to lung
epithelial cells. One of the AMP’s that were
found to be upregulated is Serum amyloid
A-3. Serum amyloid A (SAA) is a 104
amino acid long AMP that is known to play
roles in cell-to-cell communication as well
as in modulating inflammatory feedback
responses5. In humans, SAA1 and SAA2
are most commonly seen to increase in
level by more than 1000-fold during an
acute-phase immune response6. A third
isoform of the protein, known as SAA3 is
seen to exist in mice, but not humans, and
it produces a similar outcome. This
response renders the protein as a
biomarker for infection, allowing us to use it
as a measurement tool following the
administration of treatment. As such, this
study aimed to validate the microarray
analysis by performing qRT-PCR ran at
various time points to better understand
the level of the gene expression over time.
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Pneumonia is an invasive disease that
results in the inflammation of the alveolar
sacs in the lungs, commonly causing fluid
retention in these sacs. The retention of
fluid thus results in the impairment of
breathing and can even cause sepsis,
often leading to death. The disease is most
commonly seen in those with illness or a
weakened immune system, such as
persons undergoing chemotherapy, and
affects close to one hundred million people
annually1.
Previous studies have indicated that the
epithelial cells of the lungs can be
stimulated to provide protection against
these pneumonias2. This stimulation was
seen to be induced by treatment consisting
of the combination of two TLR agonists.
The first agonist, TLR2/6 is a heterodimer
that recognizes diacylated lipopeptides
such as Pam2CSK4 (Pam2), an immune
modulator that contributes to the early
immune response after infection by a
pathogen3. The second receptor that is
used in conjunction with TLR 2/6 is TLR9.
TLR9 works by binding un-methylated
cytosine-guanine dinucleotide (CpG) motifs
in both bacteria and viruses, which triggers
signaling cascades, also resulting in the

The results show SAA3 is expressed
significantly at 2 hours and 4 hours due to
Pam2-ODN treatment. Pam2-ODN induces
a protective response through AMPs such
as SAA3, especially at these frames in the
MLE cell line.
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Fig. 2 qRT-PCR analysis of SAA3 gene expression in
MLE15 cells induced by Pam2-ODN at time frames of 1
hour, 2 hours, 3 hours, 4 hours, and 6 hours, relative to
housekeeping gene 18s. n=5-6 samples/group. *p<0.05,
**p<0.001.
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